le mercredi 17 octobre 2018, à 01:52. Posté
par Teddy
I'm on work experience https://www.wnif.co.uk/dekalbhealthnet-e0ab.pdf dekalbhealth.net An experimental drug for Duchenne muscular dystrophy fromGlaxoSmithKline and Prosensa failed to meet its goal in alate-stage clinical trial, the companies said on Friday. Thedrug, drisapersen, did not show a statistically significantimprovement in the distance that patients could walk in sixminutes compared to a placebo in the Phase three test.